Raushan T Kurmasheva (Raushan Kumasheva, Raushan Kurmasheva)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Topics

Childhood Cancer

Top Venues

Pediatric blood & cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Elena Mironova, Sebastian Molinas, Vanessa Del Pozo, Abhik M Bandyopadhyay, Zhao Lai, Dias Kurmashev, Eric L Schneider, Daniel V Santi, Yidong Chen, Raushan T Kurmasheva
Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors. Cancers 16 (11) (2024)
Elena Mironova, Sebastian Molinas, Vanessa Del Pozo, Abhik M Bandyopadhyay, Zhao Lai, Dias Kurmashev, Eric L Schneider, Daniel V Santi, Yidong Chen, Raushan T Kurmasheva
Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors. Cancers 16 (11) (2024)
Elena Mironova, Sebastian Molinas, Vanessa Del Pozo, Abhik M Bandyopadhyay, Zhao Lai, Dias Kurmashev, Eric L Schneider, Daniel V Santi, Yidong Chen, Raushan T Kurmasheva
Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors. Cancers 16 (11) (2024)
Brian Mooney, Gian Luca Negri, Taras Shyp, Alberto Delaidelli, Hai-Feng Zhang, Sandra Elizabeth Spencer, Amber K Weiner, Alexander B Radaoui, Rawan Shraim, Michael M Lizardo, Christopher S Hughes, Amy Li, Amal M El-Naggar, Melanie Rouleau, Wei Li, Dimiter S Dimitrov, Raushan T Kurmasheva, Peter J Houghton, Sharon J Diskin, John M Maris, Gregg B Morin, Poul H Sorensen
Surface and global proteome analyses identify ENPP1 and other surface proteins as actionable immunotherapeutic targets in Ewing sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Funan He, Abhik M Bandyopadhyay, Laura J Klesse, Anna Rogojina, Sang H Chun, Erin Butler, Taylor Hartshorne, Trevor Holland, Dawn Garcia, Korri Weldon, Luz-Nereida Perez Prado, Anne-Marie Langevin, Allison C Grimes, Aaron Sugalski, Shafqat Shah, Chatchawin Assanasen, Zhao Lai, Yi Zou, Dias Kurmashev, Lin Xu, Yang Xie, Yidong Chen, Xiaojing Wang, Gail E Tomlinson, Stephen X Skapek, Peter J Houghton, Raushan T Kurmasheva, Siyuan Zheng
Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer. Nature communications 14 (1) (2023)
Fuyang Li, Kathryn M Bondra, Samson Ghilu, Adam Studebaker, Qianqian Liu, Joel E Michalek, Mari Kogiso, Xiao-Nan Li, John A Kalapurakal, C David James, Sandeep Burma, Raushan T Kurmasheva, Peter J Houghton
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Yifei Wang, Xiangjun Tian, Wendong Zhang, Zhongting Zhang, Rossana Lazcano, Pooja Hingorani, Michael E Roth, Jonathan D Gill, Douglas J Harrison, Zhaohui Xu, Sylvester Jusu, Sankaranarayanan Kannan, Jing Wang, Alexander J F Lazar, Eric Jay Earley, Stephen W Erickson, Tara Gelb, Philip Huxley, Johanna Lahdenranta, Gemma E Mudd, Raushan T Kurmasheva, Peter J Houghton, Malcolm A Smith, Edward Anders Kolb, Richard G Gorlick
Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma. Molecular cancer therapeutics 21 (6) (2022)
Douglas J Harrison, Jonathan D Gill, Michael E Roth, Pooja Hingorani, Wendong Zhang, Beverly Teicher, Eric Jay Earley, Stephen Erickson, Gregory Gatto, Raushan T Kurmasheva, Peter Houghton, Malcolm Smith, E Anders Kolb, Richard Gorlick
Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma. Pediatric blood & cancer 70 (1) (2022)
Pooja Hingorani, Wendong Zhang, Zhongting Zhang, Zhaohui Xu, Wei-Lien Wang, Michael E Roth, Yifei Wang, Jonathan D Gill, Douglas J Harrison, Beverly A Teicher, Stephen W Erickson, Gregory Gatto, Edward Anders Kolb, Malcolm A Smith, Raushan T Kurmasheva, Peter J Houghton, Richard G Gorlick
Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium. Molecular cancer therapeutics 21 (8) (2022)
Raushan T Kurmasheva, Stephen W Erickson, Ruolan Han, Beverly A Teicher, Malcolm A Smith, Michael Roth, Richard Gorlick, Peter J Houghton
In vivo evaluation of the lysine-specific demethylase (KDM1A/LSD1) inhibitor SP-2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC). Pediatric blood & cancer 68 (11) (2021)
Shicheng Yang, Mia Wallach, Apurva Krishna, Raushan T Kurmasheva, Srinivas Sridhar
Recent Developments in Nanomedicine for Pediatric Cancer. Journal of clinical medicine 10 (7) (2021)
Nathan M Kendsersky, Jarrett Lindsay, E Anders Kolb, Malcolm A Smith, Beverly A Teicher, Stephen W Erickson, Eric Jay Earley, Yael P Mosse, Daniel Martinez, Jennifer Pogoriler, Kateryna Krytska, Khushbu Patel, David Groff, Matthew Tsang, Samson Ghilu, Yifei Wang, Steven Seaman, Yang Feng, Brad St Croix, Richard G Gorlick, Raushan T Kurmasheva, Peter J Houghton, John M Maris
The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Samson Ghilu, Raushan T Kurmasheva, Peter J Houghton
Developing New Agents for Treatment of Childhood Cancer: Challenges and Opportunities for Preclinical Testing. Journal of clinical medicine 10 (7) (2021)
Raushan T Kurmasheva, Stephen W Erickson, Eric Earley, Malcolm A Smith, Peter J Houghton
In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models-A report from the Pediatric Preclinical Testing Consortium. Pediatric blood & cancer 68 (2) (2020)
Shaun D Fontaine, Gary W Ashley, Peter J Houghton, Raushan T Kurmasheva, Morgan Diolaiti, Alan Ashworth, Cody J Peer, Ryan Nguyen, William D Figg, Denis R Beckford-Vera, Daniel V Santi
A Very Long-Acting PARP Inhibitor Suppresses Cancer Cell Growth in DNA Repair-Deficient Tumor Models. Cancer research 81 (4) (2020)
Jonathan D Gill, Wendong Zhang, Zhongting Zhang, Michael Roth, Douglas J Harrison, Sudie Rowshan, Stephen Erickson, Gregory Gatto, Raushan T Kurmasheva, Peter Houghton, Beverly Teicher, Malcolm A Smith, E Anders Kolb, Richard Gorlick
Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium. Pediatric blood & cancer 67 (10) (2020)
Raushan T Kurmasheva, Abhik Bandyopadhyay, Edward Favours, Vanessa Del Pozo, Samson Ghilu, Doris A Phelps, Gerard M McGeehan, Stephen W Erickson, Malcolm A Smith, Peter J Houghton
Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium. Pediatric blood & cancer 67 (7) (2020)
E Anders Kolb, Peter J Houghton, Raushan T Kurmasheva, Yael P Mosse, John M Maris, Stephen W Erickson, Yuelong Guo, Beverly A Teicher, Malcolm A Smith, Richard Gorlick
Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium report. Pediatric blood & cancer 67 (5) (2020)
Andrew J Robles, Raushan T Kurmasheva, Abhik Bandyopadhyay, Doris A Phelps, Stephen W Erickson, Zhao Lai, Dias Kurmashev, Yidong Chen, Malcolm A Smith, Peter J Houghton
Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (12) (2020)
Douglas J Harrison, Jonathan D Gill, Michael E Roth, Wendong Zhang, Beverly Teicher, Stephen Erickson, Greg Gatto, Raushan T Kurmasheva, Peter J Houghton, Malcolm A Smith, Edward Anders Kolb, Richard Gorlick
Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium. Pediatric blood & cancer 67 (6) (2020)
Luke Jones, Hannah McCalmont, Kathryn Evans, Chelsea Mayoh, Raushan T Kurmasheva, Catherine A Billups, Peter J Houghton, Malcolm A Smith, Richard B Lock
Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts. Pediatric blood & cancer 66 (8) (2019)
Raushan T Kurmasheva, Abhik Bandyopadhyay, Edward Favours, Vanessa Del Pozo, Samson Ghilu, Doris A Phelps, Stephen W Erickson, Cody J Peer, William D Figg, Malcolm A Smith, Peter J Houghton
Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models. Pediatric blood & cancer 66 (8) (2019)
Abhik Bandyopadhyay, Edward Favours, Doris A Phelps, Vanessa Del Pozo, Samson Ghilu, Dias Kurmashev, Joel Michalek, Aron Trevino, Denis Guttridge, Cheryl London, Kenji Hirotani, Ling Zhang, Raushan T Kurmasheva, Peter J Houghton
Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models. Pediatric blood & cancer 65 (2) (2017)
Raushan T Kurmasheva, Dias Kurmashev, C Patrick Reynolds, Min Kang, Jianwrong Wu, Peter J Houghton, Malcolm A Smith
Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program. Pediatric blood & cancer 65 (2) (2017)